-+ 0.00%
-+ 0.00%
-+ 0.00%

MONOPAR THERAPEUTICS INC. : LEERINK PARTNERS RAISES TARGET PRICE TO $145 FROM $115

Reuters·08/13/2026 04:00:55

Please log in to view news